Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. India
  4. Bombay Stock Exchange
  5. Syngene International Limited
  6. Summary
    539268   INE398R01022

SYNGENE INTERNATIONAL LIMITED

(539268)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Bombay Stock Exchange
10/08/2021 10/11/2021 10/12/2021 10/13/2021 10/14/2021 Date
624.5 622.7 615.05 616.55 612.65 Last
33835 16029 38650 28917 25035 Volume
+0.41% -0.29% -1.23% +0.24% -0.63% Change
Estimated financial data (e)
Sales 2022 25 547 M 341 M 341 M
Net income 2022 4 365 M 58,2 M 58,2 M
Net cash position 2022 4 104 M 54,7 M 54,7 M
P/E ratio 2022 56,1x
Yield 2022 0,08%
Sales 2023 30 088 M 401 M 401 M
Net income 2023 5 729 M 76,4 M 76,4 M
Net cash position 2023 7 681 M 102 M 102 M
P/E ratio 2023 42,7x
Yield 2023 0,09%
Capitalization 243 B 3 239 M 3 239 M
EV / Sales 2022 9,35x
EV / Sales 2023 7,82x
Nbr of Employees 5 437
Free-Float 28,7%
More Financials
Company
Syngene International Limited is a contract research company. The Company is engaged in providing contract research and manufacturing services in early-stage drug discovery and development to pharmaceutical and biotechnology companies. Its services include discovery chemistry and biology services, toxicology, pharmaceutical development, process development/manufacture of intermediates, active pharmaceutical... 
More about the company
Ratings of Syngene International Limited
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
-
More Ratings
All news about SYNGENE INTERNATIONAL LIMITED
07/20SYNGENE INTERNATIONAL : Consolidated Net Profit Climbs in Fiscal Q1
MT
07/20Syngene International Limited Announces Resignation of John M M Shaw from the Board of ..
CI
07/20Syngene International Limited Reports Earnings Results for the First Quarter Ended June..
CI
06/22Syngene International Limited Appoints Dr. Kush Parmar as an Additional Director (Indep..
CI
05/26DYADIC INTERNATIONAL : Syngene to Join Forces for COVID-19 Vaccine Production
MT
05/26SYNGENE INTERNATIONAL : Dyadic announces development of COVID-19 Vaccine in India
AQ
05/26Dyadic International, Inc. Enters into Collaboration with Syngene International Limited
CI
04/28BIOCON : Syngene targets delivering 500,000 vials of remdesivir in India as COVID-19 surge..
RE
04/28SYNGENE INTERNATIONAL : Posts Higher Profit in January-March
MT
04/27Syngene International Limited Reports Earnings Results for the Fourth Quarter Ended Mar..
CI
04/27Syngene International Limited Announces No Dividend for the Financial Year 2020-2021
CI
04/01SYNGENE INTERNATIONAL : Picks Minority Stake in HR Kaveri
MT
01/20Syngene International Limited Reports Earnings Results for the Third Quarter Ended Dece..
CI
2020Syngene International Limited to Undertake Scaled Manufacture Feasibility Studies Prior..
CI
2020SYNGENE INTERNATIONAL : Arm Collaborates with US Firm for Therapeutic Discovery Projects
MT
More news
News in other languages on SYNGENE INTERNATIONAL LIMITED

- No features available -

More news
Chart SYNGENE INTERNATIONAL LIMITED
Duration : Period :
Syngene International Limited Technical Analysis Chart | 539268 | INE398R01022 | MarketScreener
Technical analysis trends SYNGENE INTERNATIONAL LIMITED
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Mean consensus -
Number of Analysts 0
Last Close Price 612,65 
Average target price
Spread / Average Target -
EPS Revisions
Managers and Directors
Jonathan Hunt Chief Executive Officer, MD & Executive Director
Sibaji Biswas Chief Financial Officer
Kiran Mazumdar-Shaw Non-Executive Chairman
Mahesh K Bhalgat Chief Operating Officer
Priyadarshini I. Mahapatra Secretary & Compliance Officer
Sector and Competitors
1st jan.Capi. (M$)
SYNGENE INTERNATIONAL LIMITED-4.21%3 239
MODERNA, INC.210.34%130 866
LONZA GROUP AG26.90%58 060
IQVIA HOLDINGS INC.38.89%47 683
SEAGEN INC.-1.38%31 426
CELLTRION, INC.-38.72%25 414